CareCentrix Earns 2021 Cigna Well-Being Award and Hartford Courant Top Workplace Recognition
HARTFORD, Conn., Sept. 27, 2021 (GLOBE NEWSWIRE) -- CareCentrix, a leader in health-at-home solutions, today announced they have been named...
Day: September 27, 2021
AGTC to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company...
Rafael Pharmaceuticals Announces APOLLO613 Phase I/II Clinical Trial of CPI-613® (devimistat) in Combination with Hydroxychloroquine in Patients with Relapsed Clear Cell Sarcoma Begins Enrollment at City of Hope in Duarte, Calif.
CRANBURY, N.J., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing...
Fierce Biotech names Tvardi Therapeutics as one of its “Fierce 15” Biotech Companies of 2021
HOUSTON, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Tvardi Therapeutics (“Tvardi”) today announced that Fierce Biotech has named it as one...
Ensysce Biosciences Announces $15 Million Convertible Note Financing
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a...
Cidara Therapeutics to Present New Data for Rezafungin at IDWeek 2021
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed...
Nemaura Medical Announces Commercial Agreement with UK Licensee
Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up Loughborough, England, Sept. 27, 2021 (GLOBE NEWSWIRE)...
BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders
VANCOUVER, British Columbia, Sept. 27, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF...
Daré Bioscience Announces NIH Grant Award to Support Development of DARE-LARC1
DARE-LARC1 Aims to Combine the Benefits of Long-acting Reversible Contraception with User-Controlled Flexibility to Pause or Resume Contraception as DesiredSAN...
Immunovant to Participate in Roivant R&D Day 2021
NEW YORK, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal...
Phathom Pharmaceuticals Announces Results from VONO-103, a Phase 1 Study Evaluating Gastric Acid Inhibition of Vonoprazan and Lansoprazole (PREVACID®)
Vonoprazan 20 mg demonstrated significantly greater acid suppressive effects over the 7-day study period compared to lansoprazole (PREVACID®) 30 mg,...
SeqLL Announces Publication of a New Blood-Based RNA Sequencing Method to Detect Coronary Artery Disease
GW-Led Research uses SeqLL’s tSMS® platform to identify novel signature for detection of coronary artery diseaseWOBURN, Mass., Sept. 27, 2021...
TOMI Environmental Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
FREDERICK, Md., Sept. 27, 2021 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (the “Company”) (NASDAQ: TOMZ), a global company specializing...
GeneTx and Ultragenyx Announce FDA has Removed Clinical Hold on Phase 1/2 Clinical Study of GTX-102 for the Treatment of Angelman Syndrome in the U.S.
SARASOTA, Fla. and NOVATO, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE),...
Fierce Biotech names Ring Therapeutics as one of its “Fierce 15” Biotech Companies of 2021
CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ring Therapeutics today announced that Fierce Biotech has named it as one...
ReWalk Robotics Announces $32.5 Million Registered Direct Offering Priced At Premium to Market
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 27, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or...
Athenex Announces Phased European Launch of Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis
Klisyri has been approved for the treatment of actinic keratosis by the UK Medicines and Healthcare products Regulatory Agency and...
Lobe Sciences to Present at the Benzinga Healthcare Small Cap Conference
Vancouver, British Columbia--(Newsfile Corp. - September 27, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...
NervGen Pharma Partners with Imeka to Use Novel Neuroimaging Technology in Clinical Trials
Vancouver, British Columbia--(Newsfile Corp. - September 27, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"),...
Miach Orthopaedics Names New CFO, Company Director
Christopher Joyce Joins as Vice President & Chief Financial Officer, Kevin Sidow Appointed to Board of Directors WESTBOROUGH, Mass.--(BUSINESS WIRE)--#ACLsurgery--Miach...